Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NHS' New Plan: 'Long-Termism' Is Also Needed In Adoption And Spread Of Technology In UK

Executive Summary

The new "NHS Long Term Plan" is an opportunity for an expansive vision in the UK, but it will fall short in its ambitious aims if it merely defaults to old, failed concepts of annualized, silo-nature NHS budgeting. These have proven to be a persistent and significant barrier to the introduction of innovation, says Peter Ellingworth, chief executive of the Association of British HealthTech Industries (ABHI).

You may also be interested in...



UK Health Care At The Crossroads As Medtechs Watch For Bill, Brexit And NHS Change

The UK health care system is keen to reshape in light of the lessons learned from COVID-19, but it comes at a time when Brexit trade issues and device regulatory system changes are already muddying the waters.

The New Culture Club: UK NHS Goes Upstream For Care Delivery And Offers New Chances For Medtechs

Hopes are high for the NHS Long Term Plan’s ability to transform health-care delivery and make a potentially unsustainable service fit for the future. There are opportunities for diagnostics, devices and digital providers, but are the resources there to turn the Plan into a success story?         

UK Medtech Industry Points The Signpost At Better Adoption of Innovation

Often seen as complicated to access, beset with high entry barriers and with no guarantee of product adoption, the UK NHS is at once a lucrative and tricky market to succeed in for medtech innovators. A new MedTech Landscape Review, from the AHSN Network, has taken on the tasks of signposting and explaining the system, its adoption pathways and its various tools and programs, in an effort to point the way for manufacturers who want to access the NHS.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT124456

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel